Back to search results

Connecting Underrepresented Populations to Cancer Clinical Trials

This study aims to help Black and Hispanic adults with cancer and their families learn about and connect with cancer clinical trials. It tests two ways to do this: a Stand-alone Research Portal, which offers existing online resources in one place, and a Portal with Virtual Community Health Educator (vCHE), which adds a virtual guide to help you navigate information. The goal is to see how many people self-refer to trials within two months of using these tools. You can join if you are 18-100 years old, can read English or Spanish, are from a racial/ethnic background often underrepresented in trials (like Black/African American or Hispanic/Latino), have email or text access, and are willing to be contacted again. The study is currently unclear on its recruitment status and plans to enroll 350 people.

Study design
This is an observational study, meaning researchers will watch and learn from participants' experiences with the two different portals. It aims to enroll 350 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Researchers will measure the proportion of patients who self-refer to cancer clinical trials within two months of consenting to participate.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05655494

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

Recruiting
Not specifiedAges 18+Observational
University of Florida
~350 participants
Updated 2026-05-08 on ClinicalTrials.gov
What's tested:Stand-alone Research PortalPortal with Virtual Community Health Educator (vCHE)

At a glance

Recruiting sites
1 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of patients who self-refer to cancer clinical trials
Measured over Within two 2 months of consent

Conditions

Cancer

Explore related trials

Breast CarcinomaColorectal CarcinomaLung CarcinomaMalignant NeoplasmMalignant Skin NeoplasmProstate Carcinoma

Where it's being run

3 sites across 1 states
Florida3

Study leadership

  • Janice Krieger, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Clinical Trials Referral Office
[email protected]
855-776-0015
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

An adult 18 to 100 years of age,
Able to read English or Spanish at least an eighth-grade level,
From a racial/ethnic background historically underrepresented in cancer clinical trials (e.g. Blacks or African Americans and/or Hispanics or Latinos),
Have an email account or the ability to receive texts,
Willingness to be re-contacted,
Be a resident of the state of Florida.

Exclusion

Unable to read English or Spanish at least at eighth-grade level
Does not have an email account or the ability to receive texts
Unwilling to be re-contacted
Non resident of the state of Florida.

What this trial measures

  • Proportion of patients who self-refer to cancer clinical trialsWithin two 2 months of consent

    Patients from underrepresented groups will be recruited in this study and equally randomized into either a) standard-of-care web-based educational portal about clinical trials or a b) a web-based portal that includes a virtual Community Health Educator. Participants in both conditions will have the opportunity to self-refer (operationalized as expressing interest in being contacted) to a cancer clinical trial. The numbers of patients referred to a cancer clinical trial will be collected in both treatment groups and the proportions compared to determine whether adding a virtual Community Health Educator to web-based educational resources about cancer clinical trials will increase referrals of minority patients. Patients are assigned into 2 groups, and the outcome measure is the number of self-referrals after treatment divided by the total number of patients for both groups.